Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital

Abroad (travel likely)Recruiting

Conditions

Gastroenteropancreatic Neuroendocrine Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France, Strasbourg, France
Contact: Study coordinator (Philippe BALTZINGER, MD) · philippe.baltzinger@chru-strasbourg.fr · 33 3 88 12 75 82
Contact: Principal Investigator (Philippe BALTZINGER, MD)
Contact: Principal Investigator (Marine HUITOREL, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Gastroenteropancreatic Neuroendocrine Tumor

Abroad (travel likely)Recruiting

East Hanover, United States

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

GEP-NET · Gastroenteropancreatic Neuroendocrine Tumor · Gastroenteropancreatic Neuroendocrine Tumor Disease

Abroad (travel likely)RecruitingPHASE1

Iowa City, United States · Lexington, United States

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Abroad (travel likely)RecruitingPHASE3

Shanghai, China · Tianjin, China

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Neuroendocrine Tumors Unresectable · Neuroendocrine Tumor Metastatic · Gastroenteropancreatic Neuroendocrine Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States · Miami, United States